Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.025
-0.025 (-1.22%)
At close: Oct 9, 2026, 4:00 PM EDT
1.986
-0.039 (-1.91%)
After-hours: Oct 9, 2026, 5:22 PM EDT
Aytu BioPharma Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Aytu BioPharma stock has a consensus rating of "Strong Buy" and an average price target of $9.50. The average 1-year stock price forecast is 369.14% higher than the current stock price, while the lowest is $7.00 (+245.68%) and the highest is $14.5 (+616.05%).
Price Target: $9.50 (+369.14%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Aytu BioPharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant | Ascendiant | Buy Maintains $15 → $15 | Buy | Maintains | $15 → $15 | +640.74% | Sep 29, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $7 | Buy | Reiterates | $7 | +245.68% | Sep 24, 2026 |
| Lake Street | Lake Street | Buy Maintains $7 | Buy | Maintains | $7 | +245.68% | Sep 23, 2026 |
Financial Forecast
Revenue This Year
67.91M
from 57.57M
Increased by 17.96%
Revenue Next Year
86.91M
from 67.91M
Increased by 27.98%
EPS This Year
-0.37
from -0.83
EPS Next Year
0.16
from -0.37
EPS and Forward PE are based on non-GAAP adjusted numbers.